Hisamitsu Financial Statements From 2010 to 2024
| HPX Stock | EUR 25.20 0.20 0.80% |
Check Hisamitsu Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hisamitsu Pharmaceutical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Hisamitsu financial statements analysis is a perfect complement when working with Hisamitsu Pharmaceutical Valuation or Volatility modules.
Hisamitsu |
Hisamitsu Pharmaceutical Co Company Profit Margin Analysis
Hisamitsu Pharmaceutical's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Hisamitsu Pharmaceutical Profit Margin | 0.10 % |
Most of Hisamitsu Pharmaceutical's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hisamitsu Pharmaceutical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Hisamitsu Pharmaceutical Co has a Profit Margin of 0.1034%. This is 100.92% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The profit margin for all Germany stocks is 108.14% lower than that of the firm.
Hisamitsu Pharmaceutical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Hisamitsu Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Hisamitsu Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Hisamitsu Pharmaceutical competition to find correlations between indicators driving Hisamitsu Pharmaceutical's intrinsic value. More Info.Hisamitsu Pharmaceutical Co is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about 0.42 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Hisamitsu Pharmaceutical Co is roughly 2.38 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Hisamitsu Pharmaceutical's earnings, one of the primary drivers of an investment's value.About Hisamitsu Pharmaceutical Financial Statements
Hisamitsu Pharmaceutical stakeholders use historical fundamental indicators, such as Hisamitsu Pharmaceutical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Hisamitsu Pharmaceutical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Hisamitsu Pharmaceutical's assets and liabilities are reflected in the revenues and expenses on Hisamitsu Pharmaceutical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Hisamitsu Pharmaceutical Co. Please read more on our technical analysis and fundamental analysis pages.
Hisamitsu Pharmaceutical Co., Inc. engages in the research and development, manufacture, purchase, and sale of pharmaceuticals in Japan. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan. HISAMITSU PHARMA operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 2770 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Hisamitsu Stock
Hisamitsu Pharmaceutical financial ratios help investors to determine whether Hisamitsu Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hisamitsu with respect to the benefits of owning Hisamitsu Pharmaceutical security.